SpringWorks Therapeutics initiates phase 3 trial of Nirogacestat in desmoid tumors

Image: The trial evaluates nirogacestat, an oral, selective, small molecule gamma-secretase inhibitor, in adult patients with desmoid tumors. Photo: Courtesy of StockSnap from Pixabay.